DK0842662T3 - Perkutant tapepræparat indeholdende fentanyl - Google Patents

Perkutant tapepræparat indeholdende fentanyl

Info

Publication number
DK0842662T3
DK0842662T3 DK97918413T DK97918413T DK0842662T3 DK 0842662 T3 DK0842662 T3 DK 0842662T3 DK 97918413 T DK97918413 T DK 97918413T DK 97918413 T DK97918413 T DK 97918413T DK 0842662 T3 DK0842662 T3 DK 0842662T3
Authority
DK
Denmark
Prior art keywords
percutaneous
preparation containing
tape preparation
containing fentanyl
fentanyl
Prior art date
Application number
DK97918413T
Other languages
Danish (da)
English (en)
Inventor
Hideharu Chono
Takaaki Terahara
Tatsuaki Suzuki
Naruhito Higo
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of DK0842662T3 publication Critical patent/DK0842662T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97918413T 1996-05-13 1997-05-13 Perkutant tapepræparat indeholdende fentanyl DK0842662T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14221096 1996-05-13
PCT/JP1997/001595 WO1997042952A1 (fr) 1996-05-13 1997-05-13 Preparation en ruban percutanee contenant du fentanyl

Publications (1)

Publication Number Publication Date
DK0842662T3 true DK0842662T3 (da) 2002-10-07

Family

ID=15309966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918413T DK0842662T3 (da) 1996-05-13 1997-05-13 Perkutant tapepræparat indeholdende fentanyl

Country Status (20)

Country Link
US (1) US6139866A (de)
EP (1) EP0842662B1 (de)
KR (1) KR100486705B1 (de)
CN (1) CN1119997C (de)
AR (1) AR007090A1 (de)
AT (1) ATE220545T1 (de)
AU (1) AU734081B2 (de)
BR (1) BR9706591A (de)
CA (1) CA2226834A1 (de)
DE (1) DE69713989T2 (de)
DK (1) DK0842662T3 (de)
ES (1) ES2176730T3 (de)
ID (1) ID16894A (de)
NO (1) NO316868B1 (de)
PL (1) PL188205B1 (de)
PT (1) PT842662E (de)
RU (1) RU2194496C2 (de)
TW (1) TW411277B (de)
WO (1) WO1997042952A1 (de)
ZA (1) ZA974073B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775903B1 (fr) * 1998-03-12 2001-06-08 Lhd Lab Hygiene Dietetique Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation
US6953590B1 (en) * 1998-10-05 2005-10-11 Yutoku Pharmaceutical Ind. Co., Ltd. Tape material for transcutaneous absorption
AU3932600A (en) * 1999-04-01 2000-10-23 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
ATE485815T1 (de) * 1999-04-13 2010-11-15 Hisamitsu Pharmaceutical Co Zubereitungen zur perkutanen absorption
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
CN100482216C (zh) * 1999-12-16 2009-04-29 德马全兹股份有限公司 氢氧根释放剂增强透皮渗透的用途
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
AU2001292781A1 (en) 2000-09-19 2002-04-02 National Starch And Chemical Investment Holding Corporation Acryl adhesive useful in transdermal drug delivery systems
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
TWI287455B (en) * 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE02715112T1 (de) * 2001-03-16 2007-04-19 Alza Corp., Mountain View Transdermales pflaster zur verabreichung von fentanyl
DE20221247U1 (de) 2001-03-16 2005-09-15 Alza Corp Transdermal-Pflaster zum Verabreichen von Fentanyl
AU2002329763B2 (en) 2001-08-17 2007-11-08 Lavipharm Laboratories Inc. Composition and transdermal drug delivery device
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
KR100844312B1 (ko) * 2001-09-06 2008-07-07 노사케미컬(주) 펜타닐 경피 투여 제제
US20030059450A1 (en) * 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
EP1437130A4 (de) * 2001-10-17 2009-08-26 Hisamitsu Pharmaceutical Co Perkutane absorptionszubereitungen
ES2307955T3 (es) * 2002-03-06 2008-12-01 Hexal Ag Sistema transdermico con fentanil.
DE60336394D1 (de) * 2002-04-23 2011-04-28 Durect Corp Transdermale analgetische systeme mit reduziertem missbrauchspotential
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097008A2 (en) * 2002-05-15 2003-11-27 Thalas Group Incorporated Transdermal delivery device for the administration of fentanyl
JP4199485B2 (ja) * 2002-06-07 2008-12-17 久光製薬株式会社 貼付剤
JP4758101B2 (ja) * 2002-09-13 2011-08-24 久光製薬株式会社 貼付剤
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JP5137286B2 (ja) 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
EP1638398A1 (de) * 2003-06-17 2006-03-29 Henkel Kommanditgesellschaft auf Aktien Hemmung der asexuellen vermehrung von pilzen durch eugenol und/oder dessen derivate
JP4468669B2 (ja) * 2003-09-22 2010-05-26 久光製薬株式会社 低刺激性貼付剤
EP1677771A2 (de) * 2003-10-30 2006-07-12 Alza Corporation Transdermale analgetische systeme mit reduziertem missbrauchspotential
DE102004028284A1 (de) * 2004-06-11 2006-01-05 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
JP4824963B2 (ja) 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
ATE471146T1 (de) 2004-10-21 2010-07-15 Durect Corp Transdermale verabreichungssysteme
DE602005010812D1 (de) * 2004-11-22 2008-12-18 Hisamitsu Pharmaceutical Co Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
EP2308480B1 (de) 2005-09-23 2014-08-13 ALZA Corporation Polyacrylatformulierung mit hoher Beladung von verstärkenden Substanzen für transdermale Anwendungen
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
US20070098772A1 (en) * 2005-09-23 2007-05-03 Westcott Tyler D Transdermal norelgestromin delivery system
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
KR101420450B1 (ko) 2006-08-04 2014-07-16 히사미쓰 세이야꾸 가부시키가이샤 첩부제
EP2123296B1 (de) * 2007-01-31 2019-05-22 Hisamitsu Pharmaceutical Co., Inc. Hilfsstoff für transdermale oder transmukosale verabreichung und pharmazeutische zubereitung damit
KR20140143461A (ko) 2007-08-06 2014-12-16 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
NZ584190A (en) 2007-10-15 2012-09-28 Alza Corp Once-a-day replacement transdermal administration of fentanyl
CN101925355B (zh) * 2008-01-28 2013-05-29 帝国制药株式会社 含芬太尼的外用贴剂
JP5738531B2 (ja) 2008-01-31 2015-06-24 久光製薬株式会社 貼付剤
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
SI2712622T1 (sl) 2008-05-21 2016-10-28 Ferring B.V. Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
KR20150036825A (ko) 2010-04-13 2015-04-07 나지브 바불 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
EP2462927A1 (de) * 2010-12-03 2012-06-13 Hexal AG Transdermales therapeutisches System mit Fentanyl
KR20120107153A (ko) * 2011-03-15 2012-10-02 아이큐어 주식회사 펜타닐 경피 패치제
EP2696677B1 (de) 2011-04-13 2021-08-11 BioSafe Technologies, Inc. Insektizide, insektenabschreckende, reizhemmende zusammensetzung
CN103930098B (zh) * 2011-09-22 2017-06-06 株式会社三养生物制药 含有芬太尼及其同族体的经皮吸收制剂
CN104507472B (zh) * 2012-07-26 2016-10-05 久光制药株式会社 贴附剂
CN103655523A (zh) * 2013-12-24 2014-03-26 南京艾德凯腾生物医药有限责任公司 他喷他多组合物
US10071090B2 (en) 2014-07-18 2018-09-11 Buzzz Pharmaceuticals Limited Oxymorphone transdermal patch
EP3233081B1 (de) * 2014-12-19 2021-09-22 Kindeva Drug Delivery L.P. Transdermale arzneimittelverabreichungsvorrichtung enthaltend fentanyl
EP3369421B1 (de) * 2015-10-26 2020-06-03 Hisamitsu Pharmaceutical Co., Inc. Hautpflaster
FR3062572B1 (fr) * 2017-02-03 2020-05-29 B. Braun Medical Composition adhesive et element de fixation sur la peau humaine
WO2021014184A1 (en) * 2019-07-19 2021-01-28 Hikma Pharmaceuticals International Limited Ready-to-administer fentanyl formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3243564B2 (ja) * 1990-08-20 2002-01-07 リードケミカル株式会社 外用貼付剤
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
JPH0640947A (ja) * 1992-07-28 1994-02-15 T T S Gijutsu Kenkyusho:Kk 経皮吸収製剤用組成物および経皮吸収製剤
RU2136319C1 (ru) * 1993-12-23 1999-09-10 Джонсон энд Джонсон Медикал, Инк. Биоабсорбируемое хирургическое гемостатическое средство и способ его получения (варианты)
DE69528165T2 (de) * 1994-04-21 2003-05-15 Hisamitsu Pharmaceutical Co., Inc. Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤

Also Published As

Publication number Publication date
RU2194496C2 (ru) 2002-12-20
NO980126L (no) 1998-03-10
CN1119997C (zh) 2003-09-03
TW411277B (en) 2000-11-11
AU734081B2 (en) 2001-05-31
KR19990028787A (ko) 1999-04-15
PL188205B1 (pl) 2004-12-31
EP0842662A4 (de) 1999-02-24
ID16894A (id) 1997-11-20
BR9706591A (pt) 1999-12-28
PL324492A1 (en) 1998-05-25
AR007090A1 (es) 1999-10-13
NO316868B1 (no) 2004-06-07
DE69713989D1 (de) 2002-08-22
PT842662E (pt) 2002-10-31
EP0842662B1 (de) 2002-07-17
EP0842662A1 (de) 1998-05-20
CN1193275A (zh) 1998-09-16
ATE220545T1 (de) 2002-08-15
US6139866A (en) 2000-10-31
DE69713989T2 (de) 2003-02-27
AU2652597A (en) 1997-12-05
HK1009746A1 (en) 1999-09-03
NO980126D0 (no) 1998-01-12
ES2176730T3 (es) 2002-12-01
ZA974073B (en) 1997-12-09
KR100486705B1 (ko) 2005-06-16
WO1997042952A1 (fr) 1997-11-20
CA2226834A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
EP0842662A4 (de) Fentanyl enthaltendes transdermal-pflaster
DE69530821D1 (de) Klebebandzusammensetzung
DE69705648D1 (de) Bandkassette
DE59808130D1 (de) Selbstklebeband
FI962618A0 (fi) Perkutaanisesti absorboituva valmiste
DE69838112D1 (de) Bandwickelsystem
DE69514679D1 (de) Bandspender
DE59605770D1 (de) Selbsklebeband
DE59710936D1 (de) Verpackungs-Klebeband
DE59908239D1 (de) Klebestreifen
DE69702791D1 (de) Bandkassette
DE69706756D1 (de) Gardinenraffband
DE69823692D1 (de) Magnetband
DE69528318D1 (de) Klebestreifen
DE59803211D1 (de) Bandhaspel
ATA73191A (de) Magazinierbares nagelband
DE69701670D1 (de) Bandkassette
ATA149597A (de) Ladenband
KR960024833U (ko) 테이프 레코더
FIU960134U0 (fi) Painonauha
KR980005067U (ko) 테이프 레코더
KR980004984U (ko) 테이프 레코더
KR970059701U (ko) 테이프 카세트
KR970059702U (ko) 카셋트 테이프 구조
KR970058384U (ko) 초배테입